This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Ryuki Miyauchi: Innovator in Molecular Conjugates
Introduction
Ryuki Miyauchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of molecular biology, particularly in the development of innovative conjugates that have potential applications in medicine.
Latest Patents
Miyauchi holds a patent for a HANP-Fc-containing molecular conjugate. This invention provides a conjugate comprising a hANP peptide bonded via a polyethylene glycol linker to a glycan attached to Asn297 of a Fc-containing molecule (N297 glycan), or a pharmaceutically acceptable salt thereof. The patent also includes a medicament comprising the same as an active ingredient, along with a method for producing the same.
Career Highlights
Ryuki Miyauchi is associated with Daiichi Sankyo Company, Limited, where he has been instrumental in advancing research and development in pharmaceutical innovations. His work has contributed to the understanding and application of molecular conjugates in therapeutic settings.
Collaborations
Miyauchi has collaborated with notable colleagues, including Mitsuhiro Iwamoto and Shohei Oishi, to further enhance the impact of his research and inventions.
Conclusion
Ryuki Miyauchi's contributions to the field of molecular conjugates exemplify the innovative spirit of modern science. His work continues to pave the way for advancements in medical treatments and therapies.